CONMED Corporation (CNMD)

Net profit margin

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net income (ttm) US$ in thousands 64,071 110,196 118,751 132,424 131,740 98,593 82,349 64,459 57,972 88,285 -93,738 -80,582 -82,722 -113,924 67,657 62,542 62,238 54,140 13,450 9,517
Revenue (ttm) US$ in thousands 1,347,471 1,326,246 1,315,998 1,307,015 1,288,116 1,275,993 1,261,548 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458
Net profit margin 4.75% 8.31% 9.02% 10.13% 10.23% 7.73% 6.53% 5.18% 4.96% 7.75% -8.53% -7.71% -7.74% -10.93% 6.63% 6.19% 6.29% 5.53% 1.53% 1.10%

September 30, 2025 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $64,071K ÷ $1,347,471K
= 4.75%


Peer comparison

Sep 30, 2025

Company name
Symbol
Net profit margin
CONMED Corporation
CNMD
4.75%
Abbott Laboratories
ABT
31.88%
Stryker Corporation
SYK
12.92%